Don Qiu, PhD, MBACo-Founder and Senior VP, Business Development at CanSino Biologics Inc
Dr. Don Qiu has extensive management experience in the biotech industry, including R&D, product development, business development, operations, technology transfer, fund raising and venture capital. Don co-founded CanSino Biologics Inc and helped the company raise a total of US$ 300 million through angel, VC, and PE fundings and a recent IPO; Don also worked for ChinaBio Group for more than five years as GM of China to lead the company consulting team finishing more than 40 projects for international pharmaceutical, venture capital and biotech companies. He also worked for HUYA Bioscience International as Managing Director of China, Wex Pharmaceutical as VP of Operations, and Beijing Joinn Pharmaceutical as CEO. Don has also served as Board Director for Suzhou GenePharma and GeneQuantum. Previously, he was with MDS Capital as Director of Asian Operations, and spent nine years in senior management positions with Biomira, AltaRex and Arius Research, taking two compounds to the clinic. He holds a PhD in Medicinal Chemistry from Peking University and an MBA from the Richard Ivey School of Business, the University of Western Ontario.